Navigation Links
Nektar Therapeutics Reports Fourth Quarter and Year-End 2008 Financial Results
Date:2/24/2009

Cost of goods sold 10,196 17,387 28,216 137,696 Other cost of revenue - 6,661 6,821 9,821 Research and development 45,279 39,310 154,417 153,575 General and administrative 13,835 14,233 51,497 57,282 Impairment of long lived assets 1,458 28,396 1,458 28,396 Gain on sale of pulmonary assets (69,572) - (69,572) - Gain on termination of collaborative agreements, net - (79,178) - (79,178) Litigation settlement - 1,583 - 1,583 Total operating costs and expenses 1,196 28,392 172,837 309,175 Income (Loss) from operations 27,156 37,381 (82,652) (36,148) Non-operating income (expense): Interest income 1,917 5,757 12,495 22,201 Interest expense (3,357) (4,230) (15,192) (18,638) Other income (expense), net (425) 944 58 1,133 Gain on extinguishment of debt 50,149 - 50,149 - Total non-operating income 48,284 2,471 47,510 4,696 Income (Loss) before provision for income taxes 75,440 39,852 (35,142) (31,452) Provision (benefit) for income taxes (1,342) 809 (806) 1,309 Net income (loss) $76,782 $39,043 $(34,336) $(32,761) Basic and diluted net earnings (loss) per share $0.83 $0.42 $(0.37) $(0.36) Shares used in computing basic and diluted net earnings (loss) per share (1) 92,473 92,211 92,407 91,876 Notes to Consolidated Statements of Operations (1) For the three-months ended December 31, 2008, there were
'/>"/>
SOURCE Nektar Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Nektar to Announce Year-End 2008 Financial Results on Wednesday, February 25, 2009 After Close of U.S.-Based Financial Markets
2. Nektar Announces Retirement of Irwin Lerner from Board of Directors
3. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at the 27th Annual J.P. Morgan Healthcare Conference in San Francisco
4. Nektar Announces Closing of Sale of Specific Pulmonary Delivery Assets to Novartis for $115 Million
5. Nektar Therapeutics to Webcast R&D Day on November 12th
6. Nektar Sells Pulmonary Business to Novartis For $115 Million and Nektar Retains Key Pulmonary Programs Including Amikacin Inhale, Inhaled Vancomycin, and Ciprofloxacin Inhalation Powder
7. Nektar Therapeutics President and CEO Howard W. Robin to Present at Natixis Bleichroeder Second Annual Hidden Gems Conference in New York City
8. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at UBS 2008 Global Life Sciences Conference in New York City
9. Nektar to Announce Financial Results for the Second Quarter of 2008 on Wednesday, August 6, 2008, After Close of U.S.-Based Financial Markets
10. Bharatt Chowrira Joins Nektar Therapeutics as Chief Operating Officer and Head of PEGylation Business Unit
11. Nektars PEGylation Technology Enables Peptide Mimetic, Highlighted by Data Presented at 45th ERA-EDTA Congress
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... 21, 2014 Prominent academics, leaders ... gather on December 3rd at Genetic Rx, a ... GeneticRx will take place at the Joseph B. ... will discuss the present and future of genetic ... and gene editing—as well as the treatment of ...
(Date:11/22/2014)... 22, 2014 The “Chiral Chromatography ... by Material (Metal, Glass, Plastic), by Application [GC, ... - Forecast to 2018” analyses and studies the ... North America, Europe, Asia, and Rest of the ... 15 figures spread through 135 pages and in-depth ...
(Date:11/21/2014)... November 21, 2014 , ...   Mariano Rodríguez es elegid vicepresidente senior ... KLOX está en marcha para comenzar de forma rápida ... heridas de reciente aprobación en Europa   , ... complace al anunciar los siguientes nombramientos: Todd ...
(Date:11/21/2014)... Author Matthew J. Pallamary’s second short ... Side” published as a tribute to his mentor ... Short Story” category of the 2014 USA Best ... of USA Book News, said this year’s contest yielded ... Simon & Schuster, Penguin, John Wiley & Sons, Houghton ...
Breaking Biology Technology:Pioneering Academics and Key Industry Leaders to Discuss Rare Diseases and the Emergence of New Genetic Medicines at Genetic Rx on December 3rd 2Chiral Chromatography Columns Market worth $87.8 Million by 2018 - New Research Report by MarketsandMarkets 2Chiral Chromatography Columns Market worth $87.8 Million by 2018 - New Research Report by MarketsandMarkets 3Chiral Chromatography Columns Market worth $87.8 Million by 2018 - New Research Report by MarketsandMarkets 4Chiral Chromatography Columns Market worth $87.8 Million by 2018 - New Research Report by MarketsandMarkets 5KLOX Technologies anuncia sus nombramientos ejecutivos 2KLOX Technologies anuncia sus nombramientos ejecutivos 3KLOX Technologies anuncia sus nombramientos ejecutivos 4KLOX Technologies anuncia sus nombramientos ejecutivos 5Mystic Ink 's Short Story Collection “A Short Walk to the Other Side” Honoring Ray Bradbury Praised As Award-Winning Finalist In USA Best Book Awards 2Mystic Ink 's Short Story Collection “A Short Walk to the Other Side” Honoring Ray Bradbury Praised As Award-Winning Finalist In USA Best Book Awards 3Mystic Ink 's Short Story Collection “A Short Walk to the Other Side” Honoring Ray Bradbury Praised As Award-Winning Finalist In USA Best Book Awards 4
... 2011 The proposed rule for the Medicare Shared ... the Department of Health and Human Services on March ... sought by the health insurance lobby, a MedeAnalytics analysis ... "The proposed rule positively addresses many of the ...
... understanding the structure of proteins, polymers, minerals, and engineered ... of the journal Nature Materials . The discovery ... type of symmetry in the structure of materials, which ... or designing materials with desired properties. The research is ...
... WHITE PLAINS, N.Y., April 1, 2011 Once again, the ... Cancer shows a continued decline in diagnoses and deaths ... attributed primarily to preventive measures such as cessation of smoking ... http://photos.prnewswire.com/prnh/20110215/NY48642LOGO) But for many cancers, such as the ...
Cached Biology Technology:ACO Proposed Rule: Over 90 Percent of Commercial Payer RFI Suggestions Incorporated 2Search for advanced materials aided by discovery of hidden symmetries in nature 2Search for advanced materials aided by discovery of hidden symmetries in nature 3The Leukemia & Lymphoma Society: Accelerating Cures Must Be a Priority 2
(Date:11/21/2014)... Wash. , Nov. 20, 2014 C-Labs ... for the Internet of Things (IoT), today announced the ... of chief operating officer. Previously a strategic advisor to ... finance, and operations. Mr. Traynor is based out of ... . He reports to Chris Muench , Chief ...
(Date:11/18/2014)... YORK , Nov. 18, 2014   ... identity authentication solutions, and MorphoTrust USA ... and services, today announced a strategic partnership to ... enterprise, motor vehicle administration (MVA), airport screening and ... in identity-related solutions, MorphoTrust serves consumers through a ...
(Date:11/7/2014)... associate professor, biomedical engineering, in the Grove School ... York, have identified a molecule that could lead ... aggressive forms of breast cancer. , Triple negative ... owing to aggressive proliferation and metastasis and a ... team, discovered the overexpression of intercellular adhesion molecule-1 ...
Breaking Biology News(10 mins):C-Labs Names Former Microsoft and Bsquare Executive as Chief Operating Officer 2EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 2EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 3
... A new study by Indiana University-Purdue University Indianapolis (IUPUI) ... fast food outlet increases weight in children and that ... as well as so called junk food, lowers weight. ... and urban planning compared children,s weights over time before ...
... from the University of Cadiz has confirmed that zinc, copper and ... of the Huelva estuary, and have studied how some of these ... cadmium and copper accumulate in the body tissues of sole and ... some metals in the waters of the Huelva estuary and those ...
... of scientists has discovered extensive similarities between a strain ... linked to opportunistic infections in hospital patients. The findings ... for a range of biotech applications. The genetic analysis ... Energy,s (DOE) Brookhaven National Laboratory, and will be published ...
Cached Biology News:IUPUI study finds living near fast food outlet not a weighty problem for kids 2Study shows transfer of heavy metals from water to fish in Huelva estuary 2Plant microbe shares features with drug-resistant pathogen 2Plant microbe shares features with drug-resistant pathogen 3
... number is a new product number, ... number. If showing no availability yet, ... number (R4276) or contact customer service ... (expanded surface, easy grip) ...
... Custom Peptide Services offer a full ... your research needs. Services include: Peptide ... Peptide synthesis, purified product (70-95% ... (acetylation, amidation, biotinylation, fluorescein, myristylation, phosphorylation, and ...
... Endogens Bovine IFNγ ELISPOT (enzyme-lined immunospot) Kit ... single cell level. A spot forms at ... is counted (either using a dissection microscope ... to the number of cells added to ...
... number is a new product ... Cornings product number. If showing ... under the old Sigma-Aldrich number ... for assistance. Material: cap ...
Biology Products: